Hetriva Transdermal Patch: Steady Cognitive Support in Dementia Care 2026

Hetriva Rivastigmine transdermal patch delivers rivastigmine steadily through the skin once daily to support cognitive function in people with mild to moderate Alzheimer's disease and Parkinson's disease dementia. It helps improve memory, attention and day-to-day functioning with fewer stomach-related side effects compared with traditional pills.

Introduction

Dementia is a progressive neurological condition that gradually affects memory, thinking, behaviour and the ability to manage daily tasks. In 2026, transdermal patch therapy remains a modern option to support cognitive symptoms while addressing practical challenges associated with oral medicines, such as swallowing difficulties and digestive side effects.

Hetriva patch provides a controlled, 24-hour delivery of rivastigmine that helps stabilise levels of acetylcholine-a neurotransmitter essential for communication between brain cells. While not a cure, Hetriva plays an important role in improving quality of life for many patients and supporting independence for longer.

Disease Overview - Dementia and Cognitive Decline

What Is Dementia?

Dementia describes a group of brain disorders that progressively impair memory, reasoning, attention and behaviour. The most common forms include:

• Alzheimer's disease - characterised by memory loss and progressive cognitive decline
• Parkinson's disease dementia -cognitive impairment associated with the progression of Parkinson's disease

As acetylcholine levels decline in affected individuals, communication between nerve cells becomes less efficient, contributing to symptoms like confusion and difficulty with day-to-day activities.

Treatment Overview - Supporting Cognitive Function

Goals of Dementia Management

Treatment of dementia focuses on:

• Preserving cognitive function
• Slowing symptom progression
• Supporting daily functioning
• Reducing behavioural symptoms

Pharmacological therapy, when appropriate, aims to improve neurotransmitter balance and support neural communication. Transdermal patches are one delivery option designed to offer smoother medication levels and enhanced tolerability.

How the Hetriva Patch Works (Mechanism of Action)

High-Level, Non-Clinical Explanation

Hetriva patch contains rivastigmine, a medication from the class known as acetylcholinesterase inhibitors. It works by increasing the concentration of acetylcholine in the brain, a key neurotransmitter involved in memory and cognitive processing.

Applied once daily to clean, dry skin, the patch releases rivastigmine through the skin and into the bloodstream steadily over 24 hours. This avoids peak-trough fluctuations seen with some oral treatments and improves overall tolerability.

Benefits of Hetriva Patch

Consistent Cognitive Support

• Provides continuous, 24-hour delivery of medication
• Helps improve memory, attention, awareness and daily functioning
• Supports better day-to-day responsiveness

Gentler on Digestion

Compared with oral pills, transdermal delivery reduces exposure to the digestive system, often resulting in fewer nausea and stomach-related side effects.

Easier for Patients and Caregivers

• Once-daily application makes adherence simpler
• Ideal for individuals who struggle with swallowing tablets
• Reduces the need for frequent medication reminders

How to Use the Hetriva Patch

Correct Application (Patient-Centred)

• Apply once daily to clean, dry, hair-free skin on the upper arm, chest, upper back or lower back.
• Press firmly for 10-15 seconds to ensure adhesion.
• Rotate application sites daily to minimise irritation.
• Avoid applying heat sources (heating pads, hot baths) directly over the patch.

Dosage and Administration

Healthcare professionals usually initiate therapy with a lower-strength patch and increase the dose over time:

• 9 mg patch - initial dose
• 18 mg patch - after approximately 4 weeks
• 27 mg patch - continued maintenance dose if tolerated

This step-up approach helps balance effectiveness with tolerability as treatment progresses.

Safety and Side Effects

Common Side Effects

Mild and generally manageable effects may include:

• Skin redness or itching at the site
• Nausea or reduced appetite
• Headache or dizziness
• Sleep disturbances
• Mild weight loss

Most side effects are temporary and tend to improve as the body adjusts to treatment.

Important Safety Notes

Consult a doctor before use if the individual has:

• A history of severe heart disease
• Liver or kidney impairment
• Breathing disorders (e.g. asthma, COPD)
• Known skin allergies or sensitivity

Patch therapy should be prescribed and monitored by a qualified healthcare professional.

FAQs

1. What is the Hetriva patch used for?

It is used to support cognitive symptoms in mild to moderate Alzheimer's and Parkinson's disease dementia.

2. How long does one patch last?

Each patch delivers medication steadily for 24 hours.

3. Where should the patch be applied?

Apply to clean, dry, hair-free areas such as the upper arm, chest or back.

4. Are side effects common?

Side effects are usually mild and include local skin irritation or mild nausea.

5. Who should avoid the patch?

Individuals with allergies to acetylcholinesterase inhibitors or certain medical conditions should consult a doctor first.

Key Takeaways

• Hetriva patch provides a steady, once-daily delivery of rivastigmine to support memory and cognition.
• Transdermal delivery improves tolerability compared with oral medicines.
• Easy application enhances adherence, especially in elderly patients.
• Safety and dosing should be guided by healthcare professionals.

Conclusion

Hetriva transdermal patch is a clinically recognised therapy for supporting cognitive symptoms in individuals with Alzheimer's disease and Parkinson's disease dementia. By delivering rivastigmine steadily through the skin, it helps stabilise acetylcholine levels in the brain, which can improve memory, thinking and day-to-day functioning while enhancing tolerability and ease of use.

For patients and caregivers seeking reliable, once-daily cognitive support in 2026 dementia care, the Hetriva patch represents a practical and well-tolerated transdermal treatment option.

PatchMantra provides expert guidance on patch therapies like Hetriva - helping you understand how they work, how they are used safely, and how they can fit into personalised care plans.